Guard Therapeutics International AB (publ)

SSE:GUARD.ST

19.8 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q2
Revenue 0000000000000000000000000000000000000000.0030.0182.8510.7152.4092.1431.5340.7070.0940
Cost of Revenue 00000000000000.00400000000000000000000000-2.703-2.505-3.277-2.3720-1.419-2.409-2.1430-1.053-1.909-1.523
Gross Profit 0000000000000-0.004000000000000000000000002.7032.5053.282.392.8512.1344.8184.2861.5341.762.0031.523
Gross Profit Ratio 0000000000000000000000000000000000000001,093.333132.77812.9852212.48921.3090
Reseach & Development Expenses 21.38314.913.02922.60331.95438.18738.24630.24119.31417.01120.73632.8849.80311.9049.0811.6867.5297.92710.8536.8828.98310.84335.53714.22412.0111.91712.59717.51512.11312.9819.40712.2298.9644.2227.0175.5736.5023.5411.6893.2222.352.3660000000
General & Administrative Expenses 1.4441.4711.4211.1081.3531.5021.2391.1461.211.3790.8940.9161.1010.7860.4960.5990.8331.1430.6170.5930.8861.3111.2191.0571.0791.3910.7640.5561.1761.0091.1251.121.1990.8851.0070.5010.6214.4673.0263.7973.2843.1572.0582.7482.8481.4611.0671.6961.438
Selling & Marketing Expenses 0.9080.9041.1130.8270.9780.8490.471.7260.9990.6480.6170.4810.6730.4880.4550.540.3540.5740.6620.5581.1590.9363.3291.3111.6781.31.6540.2625.151.7021.3351.0291.5831.4872.0730.8541.2290.7970.9340.620.5990.5940000000
SG&A 2.3522.3752.5341.9352.3312.3511.7092.8722.2092.0271.5111.3971.7741.2740.9511.1391.1871.7171.2791.1512.0452.2474.5482.3682.7572.6912.4180.8186.3262.7112.462.1492.7822.3723.081.3551.854.4673.0263.7973.2843.1572.0582.7482.8481.4611.0671.6961.438
Other Expenses 000000.08-1.4571.0130.3360.108-0.2990.1810.0240.094-0.143000000000000000-0.200.0230.014-0.120.001-0.0141.1830.9411.1910.7080.7960.960.8560.8461.0140.8640.8740.931
Operating Expenses 23.73517.27515.56324.44834.67840.61838.49834.12621.85919.14621.94834.46211.60113.2729.88812.8258.7169.64412.1328.03311.02813.0940.08516.59214.76714.60815.01518.33318.43915.69121.66714.37811.7696.6089.9776.9298.3385.653.9674.9883.9923.9533.0183.6043.6942.4751.9312.572.369
Operating Income -23.735-17.275-15.563-24.447-34.678-40.618-39.79-34.126-21.859-19.146-22.565-34.462-11.601-13.272-9.89-12.825-8.716-9.644-12.132-8.034-11.028-13.09-40.086-16.592-14.766-14.608-15.015-18.333-18.44-15.691-21.668-14.378-11.769-6.608-9.977-6.929-8.338-2.947-1.464-1.711-1.62-1.102-0.884-1.195-1.551-0.941-0.171-0.567-0.846
Operating Income Ratio 000000000000000000000000000000000000000-570.333-90-0.387-1.236-0.496-0.724-0.613-0.242-6.0320
Total Other Income Expenses Net -0.1392.768-1.5331.1051.7130.698-0.7011.7570.8590.167-0.148-0.1810.018-0.094-0.0010-0.004-0.005-0.017-0.0010-0.854-0.140-0.018-0.49800-0.1630-0.001-0.016-0.0010-0.8540-1.60300.102-0.029-0.163-0.178-0.121-0.184-0.109-0.1780.0240.0140
Income Before Tax -23.874-14.507-17.096-23.342-32.965-39.92-40.491-32.369-21-18.979-22.713-34.462-11.583-13.272-9.891-12.825-8.72-9.649-12.149-8.034-11.028-13.944-40.226-16.592-14.784-15.106-15.015-18.333-18.603-15.691-21.668-14.394-11.77-6.608-10.831-6.929-9.941-2.947-1.36-1.74-1.783-1.28-1.005-1.379-1.66-1.119-0.147-0.553-0.846
Income Before Tax Ratio 000000000000000000000000000000000000000-580-99.056-0.449-1.406-0.572-0.775-0.729-0.208-5.8830
Income Tax Expense 0-0.00415.5481.1451.594-0.70.701-3.515-0.86-0.3340.148-0.221-0.019-0.0940.00100.0040.0050.017-0.00100.8540.1400.0180.498000.1630-2.251-0.037-0.038-0.036-0.03701.6030-0.1020.0010.1630.1780.1210.1840.1090.178-0.024-0.0140
Net Income -23.874-14.507-17.096-23.342-32.965-39.22-41.192-28.854-20.14-18.645-22.713-34.462-11.583-13.272-9.891-12.825-8.72-9.649-12.149-8.034-11.028-13.944-40.226-16.592-14.784-15.106-15.015-18.333-18.603-15.691-19.417-14.357-11.732-6.572-10.795-6.929-9.941-2.947-1.36-1.74-1.783-1.28-1.005-1.379-1.66-1.119-0.147-0.553-0.846
Net Income Ratio 000000000000000000000000000000000000000-580-99.056-0.449-1.406-0.572-0.775-0.729-0.208-5.8830
EPS -2.33-1.44-1.7-2.32-3.28-3.9-5.42-0.084-0.058-0.054-0.066-0.16-0.05-0.062-0.062-0.083-0.055-0.063-0.092-0.062-0.088-0.13-1.06-0.44-0.39-1-0.88-1.24-1.26-3.14-3.36-2.49-2.04-1.61-2.67-1.8-2.58-0.88-0.42-0.45-0.55-0.71-0.49-0.66-0.98-0.54-0.071-0.27-0.41
EPS Diluted -2.33-1.44-1.7-2.32-3.28-3.9-5.42-0.084-0.058-0.054-0.066-0.16-0.05-0.062-0.062-0.083-0.055-0.063-0.092-0.062-0.088-0.13-1.06-0.44-0.39-1-0.88-1.24-1.26-3.14-3.36-2.49-2.04-1.61-2.67-1.8-2.58-0.88-0.42-0.45-0.55-0.71-0.49-0.66-0.98-0.54-0.071-0.27-0.41
EBITDA -23.689-17.275-17.096-23.342-32.962-39.918-40.491-32.369-20.999-18.979-22.713-34.462-11.582-13.268-9.85-12.785-8.238-9.166-8.471-7.793-10.787-12.848-20.618-15.609-13.729-13.58-14.479-17.606-18.166-15.582-21.463-13.303-11.192-6.475-12.085-6.498-8.296-2.902-1.43-1.685-1.593-1.082-0.82-1.109-1.532-0.928-0.141-0.551-0.844
EBITDA Ratio 000000000000000000000000000000000000000-561.667-88.5-0.38-1.147-0.46-0.715-0.605-0.199-5.8620